Alpha Tau to Participate in Five September Investor Conferences

Provided By GlobeNewswire

Last update: Aug 27, 2025

JERUSALEM, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT^®, today announced that CFO Raphi Levy will present and meet investors in the following five investor conferences in September 2025.

Read more at globenewswire.com

ALPHA TAU MEDICAL LTD

NASDAQ:DRTS (11/26/2025, 8:27:27 PM)

3.74

-0.16 (-4.1%)

DRTS Overview

DRTS Technical Analysis Report

DRTS Fundamental Analysis Report

ALPHA TAU MEDICAL LTD -27

NASDAQ:DRTSW (11/26/2025, 8:27:27 PM)

0.3425

+0 (+0.74%)